© Reuters.
BAUDETTE, MN – ANI Pharmaceuticals, Inc. (NASDAQ: NASDAQ:), a diversified biopharmaceutical company, has announced its participation in the upcoming Leerink Partners Global Biopharma Conference. The event is scheduled to take place on Tuesday, March 12, 2024, at 2:20 p.m. ET in Miami Beach.
The company’s Chief Executive Officer, Nikhil Lalwani, and Chief Financial Officer, Stephen Carey, will represent ANI Pharmaceuticals at the conference. Interested parties can access a live webcast of the presentation through the Investors section of the company’s website, where it will also be archived for 90 days post-event.
ANI Pharmaceuticals specializes in developing, manufacturing, and marketing branded and generic prescription pharmaceuticals. The company places a strong emphasis on addressing diseases with high unmet medical needs. Currently, ANI Pharmaceuticals is…
